Pharmaceuticals

Investigational, Once-weekly Insulin Icodec Showed Comparable Efficacy and Safety to Once-daily Insulin Glargine U100 in Phase 2 Trial

This material is intended for global medical media only, excl US  For journalistic assessment and preparation before publication.  BAGSVÆRD, Denmark, June 15, 2020 /PRNewswire/ -- Today, Novo Nordisk announced results from a phase 2 clinical trial of investigational insulin icodec, a once-week...

2020-06-15 07:30 823

Switching to Ozempic(R) from another GLP-1 RA significantly reduced blood sugar and weight in people with type 2 diabetes in routine clinical practice

This material is intended for global medical media only, excl US. For journalistic assessment and preparation before publication. - A separate real-world study showed that people with type 2 diabetes on two oral antidiabetic drugs who intensified with a glucagon-like peptide-1 receptor agonist ...

2020-06-15 06:15 796

I-Mab and ABL Bio to Present Preclinical Data for Joint Bispecific Antibody Program at the 2020 American Association for Cancer Research Virtual Meeting II

SHANGHAI and GAITHERSBURG, Md., June 12, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, will be presenting preclinical data on a newly developed, novel asset TJ...

2020-06-12 20:00 5938

Harbour BioMed Appoints Dr. Jon Wigginton to its Scientific Advisory Board

CAMBRIDGE, Mass, ROTTERDAM, Netherlands and SUZHOU, China, June 11, 2020 /PRNewswire/ -- Harbour BioMed (HBM) announced today the appointment of Dr.Jon Wigginton M.D., to the company's scientific advisory board (SAB). Dr. Wigginton is a physician-scientist and leader in immuno-oncology drug devel...

2020-06-11 18:00 1003

PharmAbcine execute an agreement with Thermo Fisher for the development and manufacturing of its next-generation immune checkpoint blockade, PMC-309 for Phase I

DAEJEON, South Korea, June 10, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) entered into a strategic partnership with Thermo Fisher Scientific for the development and manufacturing of PMC-309, a next-generation immune checkpoint blockade to treat cancer. Under this agreement, PharmA...

2020-06-11 00:00 297

Menarini Group Completes a Solid Year of Operating Performance

- Turnover reaches €3,793 million, with an increase of 3.2% compared to 2018 and EBITDA of €492 million thanks to continued strong performance of its most important products - €150 million investment into new plant in Italy significantly increasing oral blister capacity in line with increased de...

2020-06-10 23:42 960

Siemens and Exyte join forces to deliver integrated solutions for fast-track construction of smart biotech facilities

Joint Press Release * Covid-19 poses major challenges for developing and mass-producing vaccines and medicines in existing production facilities * Siemens and Exyte combine their strengths to offer intelligent, modular, and scalable biotech facilities * Siemens provides solutions for proces...

2020-06-10 08:45 421

Collaborating in Innovative Medical R&D to combat the pandemic, Alphamab Oncology and Institut Pasteur Shanghai Announce Partnership to Co-develop COVID-19 Neutralizing Antibody

SUZHOU, China, June 9, 2020 /PRNewswire/ -- Alphamab Oncology (stock code: 9966 HK) announced that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. ("Jiangsu Alphamab"), a wholly-owned subsidiary of the Company, has entered a partnership agreement with Institut Pasteur ofShanghai, Chinese Academy of...

2020-06-10 08:40 4810

L.E.A.F. Pharmaceuticals Lead Investigational Product for Lung and Colorectal Cancers, LEAF-1401, Featured at the 2020 Virtual Annual Meeting of the American Society of Clinical Oncology (ASCO)

Treatment with LEAF-1401 exposes the tumor to 20-times more pentaglutamated pemetrexed than conventional pemetrexed. Polyglutamated pemetrexed has been shown to be 80-times more potent than pemetrexed in inhibiting thymidylate synthase (TS), a key enzyme in the folate pathway. Pemetrexed (Alimta®...

2020-06-10 03:15 372

Frost & Sullivan Names Top Innovators in Artificial Intelligence for Drug Discovery in the Pharmaceutical Industry

The Frost Radar benchmarks the top 16 companies in the market excelling at growth and innovation SANTA CLARA, California, June 10, 2020 /PRNewswire/ -- Frost & Sullivan's Artificial Intelligence for Drug Discovery in the Pharmaceutical Industry Radar has identified that organizations' need to mi...

2020-06-10 00:41 375

Alphamab Oncology and Sanofi Enter Collaboration on KN026 in HER2+ Breast Cancer

SUZHOU, China, June 8, 2020 /PRNewswire/ -- Alphamab Oncology (stock code: 9966 HK) a clinical stage biopharmaceutical company focusing on innovative biologics medicine for oncology, and Sanofi (EURONEXT: SAN and NASDAQ: SNY), a global biopharmaceutical leader, announced today that Jiangsu Alpham...

2020-06-09 10:10 4747

WuXi Biologics Signs Lease for a Clinical Manufacturing Facility in the United States

CRANBURY, NJ and SHANGHAI, June 9, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has signed a 10-year lease for a clinical manufacturing facility (MFG18) inCranbury, New Jersey. The new clin...

2020-06-09 08:00 238

Healios Successfully Establishes Proprietary Universal Donor Cell Research Line

TOKYO, June 5, 2020 /PRNewswire/ -- Healios K.K. (hereinafter "the Company"; TSE: 4593),Japan's leading clinical-stage biotechnology company, has been creating Universal Donor Cells (UDCs), which are next-generation iPS cells created with gene-editing technology to engineer a low risk of immune r...

2020-06-05 13:00 1364

Update: Deadline To File Claims Against Purdue Pharma L.P. Has Been Extended To July 30, 2020

NEW YORK, June 5, 2020 /PRNewswire/ -- The following is being issued by Prime Clerk LLC. In light of the ongoing COVID-19 pandemic, the U.S. Bankruptcy Court for the Southern District ofNew York has granted a 30-day extension of the deadline to file a claim against Purdue Pharma L.P.,1 including...

2020-06-05 01:19 1631

IPP Announces AGC Biologics Acquisition of AstraZeneca Boulder, CO Plant

PRINCETON JUNCTION, New Jersey, June 4, 2020 /PRNewswire/ -- International Process Plants (IPP), a global buyer and seller of pharmaceutical and biopharmaceutical manufacturing facilities and equipment, announced its client AGC Biologics' successful Q2/20 purchase of a state-of-the-art commercial...

2020-06-04 21:34 1698

Servier Completes the Acquisition of Symphogen

PARIS, June 4, 2020 /PRNewswire/ -- Servier, an independent international pharmaceutical company, today announced that it has completed the acquisition of Symphogen A/S. Symphogen will now function as Servier's antibody center of excellence across multiple therapeutic areas, including oncology. ...

2020-06-04 21:30 1121

Press Launch of hVIVO COVID Clear Test, the Most Accurate Antibody Test Available to UK Employers to Help Get People Back to Work

Thursday 4 June 2020, 11am at hVIVO's world leading virology clinic in Whitechapel,East London We are making available for the first time on demand antibody testing direct to large employer groups in the UK We are also seeking channel partners to make testing available through GP networks, nurs...

2020-06-04 14:00 1421

China Jo-Jo Drugstores Announces the Closing of $10 Million Registered Direct Offering

HANGZHOU, China, June 3, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ CM: CJJD) (the "Company" or "China Jo-Jo"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that it clos...

2020-06-04 04:00 10855

Clarity Pharmaceuticals Announces that the US FDA Grants Rare Pediatric Disease Designation to 67Cu-SARTATE™ for the Treatment of Neuroblastoma

SYDNEY, June 3, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to67Cu-SARTATE™, a therapy for th...

2020-06-03 21:08 674

Novavax Selects AGC Biologics to Manufacture Matrix-M™ Adjuvant for Novel COVID-19 Vaccine

AGC Biologics partners with Novavax to produce NVX-CoV2373 component SEATTLE, June 3, 2020 /PRNewswire/ -- AGC Biologics, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced that it will partner withNovavax, Inc. (NASDAQ: NVAX), a late-stage biot...

2020-06-03 19:00 1301
123456 ... 123